Joshua J. Short, Ph.D.

Affiliations:	2004		University of Alabama, Birmingham, Birmingham, AL, United States
	2013-2015	Pediatric Surgery	Mott Children's Hospital, Ann Arbor, MI, United States
	2015-	Pediatric Surgery	Children's Hospitals of Minnesota, Saint Paul, MN, United States

David T. Curiel	grad student	2004	UAB
(Identification and characterization of adenovirus serotype 3 primary cellular attachment receptors.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Short JJ, Rivera AA, Wu H, et al. (2010) Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy. Molecular Cancer Therapeutics. 9: 2536-44
Short JJ, Curiel DT. (2009) Oncolytic adenoviruses targeted to cancer stem cells. Molecular Cancer Therapeutics. 8: 2096-102
Short JJ, Vasu C, Holterman MJ, et al. (2006) Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors. Virus Research. 122: 144-53
Short JJ, Pereboev AV, Kawakami Y, et al. (2004) Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors. Virology. 322: 349-59
Short JJ, Pereboev AV, Kawakami Y, et al. (2004) 116. Members of Adenovirus Subgroup B Utilize CD80 (B7.1) and CD86 (B7.2) as Primary Cellular Attachment Receptors Molecular Therapy. 9
Takayama K, Reynolds PN, Short JJ, et al. (2003) A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology. 309: 282-93